A Study in Patients With Trichotillomania

PHASE2CompletedINTERVENTIONAL
Enrollment

128

Participants

Timeline

Start Date

December 19, 2018

Primary Completion Date

December 2, 2019

Study Completion Date

December 16, 2019

Conditions
Trichotillomania
Interventions
DRUG

SXC-2023

SXC-2023 oral capsules

DRUG

Placebo

Matching Placebo oral capsules

Trial Locations (13)

11229

Integrative Clinical Trials, LLC, Brooklyn

14618

Finger Lakes Clinical Research, Rochester

29407

Carolina Clinical Trials, Inc, Charleston

30030

iResearch Atlanta, Decatur

33161

Behavioral Clinical Research, North Miami

44122

Insight Clinical Trials, LLC, Shaker Heights

60637

Univ of Chicago, Chicago

70629

Lake Charles Clinical Trials, Lake Charles

73103

IPS Research Company, Oklahoma City

90662

CNRI- Los Angeles, Pico Rivera

92503

Artemis Institute for Clinical Research, Riverside

98007

Northwest Clinical Research Center, Bellevue

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

Promentis Pharmaceuticals, Inc.

INDUSTRY

NCT03797521 - A Study in Patients With Trichotillomania | Biotech Hunter | Biotech Hunter